Perceptive Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-168,000
| Closed | -$6.61M | – | 112 |
|
|
2023
Q2 | $6.61M | Sell |
168,000
-332,000
| -66% | -$11.7M | 0.19% | 72 |
|
|
2023
Q1 | $12.2M | Sell |
500,000
-87,400
| -15% | -$1.91M | 0.36% | 59 |
|
|
2022
Q4 | $12.6M | Sell |
587,400
-446,769
| -43% | -$9.5M | 0.35% | 57 |
|
|
2022
Q3 | $18.6M | Sell |
1,034,169
-1,053,787
| -50% | -$13.8M | 0.54% | 47 |
|
|
2022
Q2 | $20.1M | Sell |
2,087,956
-3,137,459
| -60% | -$39.4M | 0.63% | 40 |
|
|
2022
Q1 | $87.9M | Sell |
5,225,415
-1,254,585
| -19% | -$18.5M | 1.83% | 14 |
|
|
2021
Q4 | $108M | Sell |
6,480,000
-991,798
| -13% | -$16.3M | 1.67% | 15 |
|
|
2021
Q3 | $121M | Buy |
7,471,798
+2,886,286
| +63% | +$31.4M | 1.76% | 13 |
|
|
2021
Q2 | $28.9M | Hold |
4,585,512
| – | – | 0.38% | 62 |
|
|
2021
Q1 | $28.3M | Buy |
4,585,512
+102,799
| +2% | +$624K | 0.36% | 62 |
|
|
2020
Q4 | $31M | Buy |
4,482,713
+1,001,282
| +29% | +$6.41M | 0.33% | 63 |
|
|
2020
Q3 | $19.6M | Hold |
3,481,431
| – | – | 0.29% | 69 |
|
|
2020
Q2 | $17.8M | Buy |
3,481,431
+2,104,142
| +153% | +$8.77M | 0.29% | 63 |
|
|
2020
Q1 | $4.74M | Buy |
1,377,289
+387,000
| +39% | +$2.26M | 0.12% | 80 |
|
|
2019
Q4 | $8.5M | Buy |
+990,289
| New | +$3.54M | 0.17% | 72 |
|
|
2017
Q2 | – | Sell |
-1,600
| Closed | -$5K | – | 164 |
|
|
2017
Q1 | $5K | Buy |
+1,600
| New | +$6.76K | ﹤0.01% | 154 |
|
|
2016
Q3 | – | Sell |
-8,145
| Closed | -$459K | – | 220 |
|
|
2016
Q2 | $416K | Buy |
+8,145
| New | +$405K | 0.03% | 132 |
|
|
2015
Q1 | – | Sell |
-429,386
| Closed | -$19.3M | – | 182 |
|
|
2014
Q4 | $19.3M | Sell |
429,386
-90,779
| -17% | -$3.81M | 1.62% | 19 |
|
|
2014
Q3 | $20.2M | Buy |
520,165
+148,696
| +40% | +$5.84M | 2.05% | 15 |
|
|
2014
Q2 | $15.7M | Buy |
371,469
+121,469
| +49% | +$4.46M | 1.54% | 20 |
|
|
2014
Q1 | $8.94M | Buy |
250,000
+175,000
| +233% | +$5.9M | 0.94% | 33 |
|
|
2013
Q4 | $2.43M | Buy |
+75,000
| New | +$2.23M | 0.29% | 45 |
|
Perceptive Advisors's ISEE Position: Q3 2023 in Review
Perceptive Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 168,000 shares — an estimated $6.61M sold.
Perceptive Advisors first reported a position in ISEE in Q4 2013 and held it in 22 quarters. The position peaked at $121M in Q3 2021. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Perceptive Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Perceptive Advisors sold 168,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $6.61M.
- Perceptive Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 22 quarters.
- Perceptive Advisors's IVERIC bio, Inc. Common Stock position peaked at $121M in Q3 2021.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Perceptive Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.